Clarify Health, a leading healthcare analytics company, announced that its life sciences software, Clarify Launch, now includes innovative enhancements that give brand teams a faster and more effective way to identify market opportunities to drive growth. The ability to explore over 300 million longitudinal patient care journeys using Clarify Launch offers brand teams rapid access to actionable insights within specific patient populations. Clarify brings first-of-their-kind patient segmentation, provider attribution, and provider scoring capabilities directly to end-users at pharmaceutical and biotechnology companies.
“Two-thirds of new drugs fall short of first year implementation expectations, and they rarely rebound. Comprehensive next-generation analytics are uniquely positioned to help pharma and biotech companies alter this trend by providing a lens that crosses all stakeholders— patients, providers, and payers”
“Two-thirds of new drugs fall short of first year implementation expectations, and they rarely rebound. Comprehensive next-generation analytics are uniquely positioned to help pharma and biotech companies alter this trend by providing a lens that crosses all stakeholders— patients, providers, and payers,” said Calum MacRae, M.D., Ph.D., Professor of Medicine at Harvard Medical School, and an advisor to Clarify Health.
The Clarify Launch software is powered by a unique network architecture and technology stack inspired by the consumer and financial services industries. This advanced technology underlies Clarify’s ability to produce and automatically improve upon predictive models for delivering precise patient and provider outcomes. Clarify Launch stands apart in the market today through its ability to derive transparent insights in a matter of seconds from a broad dataset that is payer-complete and includes socio-behavioral determinants of health, linked claims, prescription, and lab data. For commercial teams who have had to rely on qualitative and anecdotal views of patient journeys for years, Clarify’s comprehensive dataset offers a detailed quantitative view of patient journeys that can be trusted to answer questions that are critical to commercial success.
“With new capabilities to address the two most critical factors for market success—speed and precision—we can better serve the life sciences sector, and ultimately the patients who need these critical therapies,” said Jean Drouin, M.D., Chief Executive Officer, Clarify Health. “The latest release of Clarify Launch further demonstrates our commitment to developing novel methods of producing actionable insights that help deliver the right drug to the right patient faster,” he said.
About Clarify Health
Clarify Health’s enterprise analytics platform empowers providers, health plans, and life sciences companies to deliver better care through actionable insights. By linking clinical, claims, prescription, lab, and social determinants of health data across over 300 million lives and leveraging industry-leading statistical modeling and machine learning, Clarify Health delivers precise insights into performance, cost, and quality.
